When Should Open-Label Extension Studies Be Stopped?

被引：0
|
作者：
Crites, Joshua S. [1 ]
机构：
[1] Penn State Coll Med, Hershey, PA 17033 USA
来源：
AMERICAN JOURNAL OF BIOETHICS | 2014年 / 14卷 / 04期
关键词：
CLINICAL-TRIALS;
D O I：
10.1080/15265161.2014.889957
中图分类号：
B82 [伦理学（道德学）];
学科分类号：
摘要：
引用
收藏
页码：57 / 58
页数：2
相关论文
共 50 条
  • [21] Interpreting efficacy outcomes from open-label extension studies of anti-epileptic drugs
    Maguire, Melissa J.
    Hemming, K.
    Hutton, J.
    Marson, A.
    EPILEPSIA, 2007, 48 : 312 - 312
  • [22] Interim Analysis of Open-Label Extension Studies of Sustained Release Fampridine in Patients with Multiple Sclerosis
    Goodman, Andrew D.
    Brown, Ted R.
    Edwards, Keith R.
    Schapiro, Randall T.
    Marinucci, Lawrence N.
    Cohen, Ron
    Blight, Andrew R.
    NEUROLOGY, 2010, 74 (09) : A101 - A101
  • [23] New lessons for an old problem: ASSET open-label extension
    Del Galdo, Francesco
    LANCET RHEUMATOLOGY, 2020, 2 (12): : E726 - E727
  • [24] Symptoms, Side Effects and Adherence in the iPrEx Open-Label Extension
    Glidden, David V.
    Amico, K. Rivet
    Liu, Albert Y.
    Hosek, Sybil G.
    Anderson, Peter L.
    Buchbinder, Susan P.
    McMahan, Vanessa
    Mayer, Kenneth H.
    David, Burns
    Schechter, Mauro
    Grinsztejn, Beatriz
    Guanira, Juan
    Grant, Robert M.
    CLINICAL INFECTIOUS DISEASES, 2016, 62 (09) : 1172 - 1177
  • [25] OPEN-LABEL STUDIES OF ADINAZOLAM IN SEVERE DEPRESSION
    PYKE, RE
    COHN, JB
    FEIGHNER, JP
    SMITH, WT
    PSYCHOPHARMACOLOGY BULLETIN, 1983, 19 (01) : 96 - 98
  • [26] Open label extension studies: research or marketing?
    Taylor, GJ
    Wainwright, P
    BRITISH MEDICAL JOURNAL, 2005, 331 (7516): : 572 - 574
  • [27] Seletalisib for Activated PI3Kδ Syndromes: Open-Label Phase lb and Extension Studies
    Diaz, Nieves
    Juarez, Maria
    Cancrini, Caterina
    Heeg, Maximilian
    Soler-Palacin, Pere
    Payne, Andrew
    Johnston, Geoffrey, I
    Helmer, Eric
    Cain, Dionne
    Mann, Joanne
    Yuill, Daisy
    Conti, Francesca
    Di Cesare, Silvia
    Ehl, Stephan
    Garcia-Prat, Marina
    Maccari, Maria Elena
    Martin-Nalda, Andrea
    Martinez-Gallo, Monica
    Moshous, Despina
    Santilli, Veronica
    Semeraro, Michaela
    Simonetti, Alessandra
    Suarez, Felipe
    Cavazzana, Marina
    Kracker, Sven
    JOURNAL OF IMMUNOLOGY, 2020, 205 (11): : 2979 - +
  • [28] Durability of Diabetic Retinopathy Improvement with As-Needed Ranibizumab Open-Label Extension of RIDE and RISE Studies
    Sun, Jennifer K.
    Wang, Pin-wen
    Taylor, Sarah
    Haskova, Zdenka
    OPHTHALMOLOGY, 2019, 126 (05) : 712 - 720
  • [29] AN OPEN-LABEL EXTENSION OF TWO CONTROLLED STUDIES OF CARISBAMATE AS ADJUNCTIVE TREATMENT OF PARTIAL ONSET SEIZURES IN ADULTS
    Halford, J.
    Kalviainen, R.
    Ben-Menachem, E.
    Schmitt, J.
    Wiegand, F.
    Novak, G.
    EPILEPSIA, 2009, 50 : 107 - 107
  • [30] AbobotulinumtoxinA (Dysport) dosing in cervical dystonia: an exploratory analysis of two large open-label extension studies
    Hauser, Robert A.
    Daniel Truong
    Hubble, Jean
    Coleman, Chandra
    Beffy, Jean-Luc
    Chang, Stephen
    Picaut, Philippe
    JOURNAL OF NEURAL TRANSMISSION, 2013, 120 (02) : 299 - 307
12345